Preoperative Treatment of Locally Advanced Rectal Cancer
In a trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy.
Gespeichert in:
Veröffentlicht in: | The New England journal of medicine 2023-07, Vol.389 (4), p.322-334 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 334 |
---|---|
container_issue | 4 |
container_start_page | 322 |
container_title | The New England journal of medicine |
container_volume | 389 |
creator | Schrag, Deborah Shi, Qian Weiser, Martin R. Gollub, Marc J. Saltz, Leonard B. Musher, Benjamin L. Goldberg, Joel Al Baghdadi, Tareq Goodman, Karyn A. McWilliams, Robert R. Farma, Jeffrey M. George, Thomas J. Kennecke, Hagen F. Shergill, Ardaman Montemurro, Michael Nelson, Garth D. Colgrove, Brian Gordon, Vallerie Venook, Alan P. O’Reilly, Eileen M. Meyerhardt, Jeffrey A. Dueck, Amylou C. Basch, Ethan Chang, George J. Mamon, Harvey J. |
description | In a trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy. |
doi_str_mv | 10.1056/NEJMoa2303269 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2822708125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2822708125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-b97cd69e77f7bab9978c0876e02234b86356a8e3e92b1621e182cc14b6653a483</originalsourceid><addsrcrecordid>eNp10NtLwzAUBvAgipvTR1-lIIIv1dyay-MY88a8IPM5pOkpbLTNTNrB_ns7NgUF83II_Pg450PonOAbgjNx-zJ9evaWMsyo0AdoSDLGUs6xOERDjKlKudRsgE5iXOL-Ea6P0YBJKmnG-BCptwB-BcG2izUk8wC2raFpE18mM-9sVW2ScbG2jYMieQfX2iqZbH_hFB2Vtopwtp8j9HE3nU8e0tnr_eNkPEsd07hNcy1dITRIWcrc5lpL5bCSAjCljOdKsExYBQw0zYmgBIiizhGeC5ExyxUboetd7ir4zw5ia-pFdFBVtgHfRUMVpRIr0p8zQpd_6NJ3oem36xWnmeAab1W6Uy74GAOUZhUWtQ0bQ7DZVmp-Vdr7i31ql9dQ_OjvDntwtQN1HU0Dy_qfoC_Wr3nr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2842564905</pqid></control><display><type>article</type><title>Preoperative Treatment of Locally Advanced Rectal Cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>New England Journal of Medicine</source><creator>Schrag, Deborah ; Shi, Qian ; Weiser, Martin R. ; Gollub, Marc J. ; Saltz, Leonard B. ; Musher, Benjamin L. ; Goldberg, Joel ; Al Baghdadi, Tareq ; Goodman, Karyn A. ; McWilliams, Robert R. ; Farma, Jeffrey M. ; George, Thomas J. ; Kennecke, Hagen F. ; Shergill, Ardaman ; Montemurro, Michael ; Nelson, Garth D. ; Colgrove, Brian ; Gordon, Vallerie ; Venook, Alan P. ; O’Reilly, Eileen M. ; Meyerhardt, Jeffrey A. ; Dueck, Amylou C. ; Basch, Ethan ; Chang, George J. ; Mamon, Harvey J.</creator><creatorcontrib>Schrag, Deborah ; Shi, Qian ; Weiser, Martin R. ; Gollub, Marc J. ; Saltz, Leonard B. ; Musher, Benjamin L. ; Goldberg, Joel ; Al Baghdadi, Tareq ; Goodman, Karyn A. ; McWilliams, Robert R. ; Farma, Jeffrey M. ; George, Thomas J. ; Kennecke, Hagen F. ; Shergill, Ardaman ; Montemurro, Michael ; Nelson, Garth D. ; Colgrove, Brian ; Gordon, Vallerie ; Venook, Alan P. ; O’Reilly, Eileen M. ; Meyerhardt, Jeffrey A. ; Dueck, Amylou C. ; Basch, Ethan ; Chang, George J. ; Mamon, Harvey J.</creatorcontrib><description>In a trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMoa2303269</identifier><identifier>PMID: 37272534</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>5-Fluorouracil ; Adult ; Anal Canal - surgery ; Antineoplastic Combined Chemotherapy Protocols - adverse effects ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Cancer ; Cancer therapies ; Chemoradiotherapy ; Chemoradiotherapy - adverse effects ; Chemoradiotherapy - methods ; Chemotherapy ; Chemotherapy, Adjuvant ; Colorectal cancer ; Death ; Disease-Free Survival ; Fluorouracil - administration & dosage ; Fluorouracil - adverse effects ; Gastroenterology ; Gastrointestinal Tract Cancer ; Hematology ; Humans ; Leucovorin - administration & dosage ; Leucovorin - adverse effects ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local - drug therapy ; Neoplasm Staging ; Oncology ; Organ Sparing Treatments ; Oxaliplatin ; Oxaliplatin - administration & dosage ; Oxaliplatin - adverse effects ; Pathology ; Patients ; Pelvis ; Preoperative Care ; Preoperative Period ; Radiation therapy ; Rectal Neoplasms - mortality ; Rectal Neoplasms - pathology ; Rectal Neoplasms - surgery ; Rectum ; Review boards ; Sphincter ; Statistical analysis ; Surgeons ; Surgery ; Survival ; Treatments in Oncology ; Tumors</subject><ispartof>The New England journal of medicine, 2023-07, Vol.389 (4), p.322-334</ispartof><rights>Copyright © 2023 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2023 Massachusetts Medical Society.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-b97cd69e77f7bab9978c0876e02234b86356a8e3e92b1621e182cc14b6653a483</citedby><cites>FETCH-LOGICAL-c390t-b97cd69e77f7bab9978c0876e02234b86356a8e3e92b1621e182cc14b6653a483</cites><orcidid>0000-0002-4334-5717 ; 0000-0003-3813-9318 ; 0000-0002-6249-9180 ; 0000-0002-8076-9199 ; 0000-0002-9912-1085</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMoa2303269$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.nejm.org/doi/full/10.1056/NEJMoa2303269$$EHTML$$P50$$Gmms$$H</linktohtml><link.rule.ids>314,776,780,2746,2747,26080,27901,27902,52357,54039</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37272534$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schrag, Deborah</creatorcontrib><creatorcontrib>Shi, Qian</creatorcontrib><creatorcontrib>Weiser, Martin R.</creatorcontrib><creatorcontrib>Gollub, Marc J.</creatorcontrib><creatorcontrib>Saltz, Leonard B.</creatorcontrib><creatorcontrib>Musher, Benjamin L.</creatorcontrib><creatorcontrib>Goldberg, Joel</creatorcontrib><creatorcontrib>Al Baghdadi, Tareq</creatorcontrib><creatorcontrib>Goodman, Karyn A.</creatorcontrib><creatorcontrib>McWilliams, Robert R.</creatorcontrib><creatorcontrib>Farma, Jeffrey M.</creatorcontrib><creatorcontrib>George, Thomas J.</creatorcontrib><creatorcontrib>Kennecke, Hagen F.</creatorcontrib><creatorcontrib>Shergill, Ardaman</creatorcontrib><creatorcontrib>Montemurro, Michael</creatorcontrib><creatorcontrib>Nelson, Garth D.</creatorcontrib><creatorcontrib>Colgrove, Brian</creatorcontrib><creatorcontrib>Gordon, Vallerie</creatorcontrib><creatorcontrib>Venook, Alan P.</creatorcontrib><creatorcontrib>O’Reilly, Eileen M.</creatorcontrib><creatorcontrib>Meyerhardt, Jeffrey A.</creatorcontrib><creatorcontrib>Dueck, Amylou C.</creatorcontrib><creatorcontrib>Basch, Ethan</creatorcontrib><creatorcontrib>Chang, George J.</creatorcontrib><creatorcontrib>Mamon, Harvey J.</creatorcontrib><title>Preoperative Treatment of Locally Advanced Rectal Cancer</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>In a trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy.</description><subject>5-Fluorouracil</subject><subject>Adult</subject><subject>Anal Canal - surgery</subject><subject>Antineoplastic Combined Chemotherapy Protocols - adverse effects</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Cancer</subject><subject>Cancer therapies</subject><subject>Chemoradiotherapy</subject><subject>Chemoradiotherapy - adverse effects</subject><subject>Chemoradiotherapy - methods</subject><subject>Chemotherapy</subject><subject>Chemotherapy, Adjuvant</subject><subject>Colorectal cancer</subject><subject>Death</subject><subject>Disease-Free Survival</subject><subject>Fluorouracil - administration & dosage</subject><subject>Fluorouracil - adverse effects</subject><subject>Gastroenterology</subject><subject>Gastrointestinal Tract Cancer</subject><subject>Hematology</subject><subject>Humans</subject><subject>Leucovorin - administration & dosage</subject><subject>Leucovorin - adverse effects</subject><subject>Neoadjuvant Therapy</subject><subject>Neoplasm Recurrence, Local - drug therapy</subject><subject>Neoplasm Staging</subject><subject>Oncology</subject><subject>Organ Sparing Treatments</subject><subject>Oxaliplatin</subject><subject>Oxaliplatin - administration & dosage</subject><subject>Oxaliplatin - adverse effects</subject><subject>Pathology</subject><subject>Patients</subject><subject>Pelvis</subject><subject>Preoperative Care</subject><subject>Preoperative Period</subject><subject>Radiation therapy</subject><subject>Rectal Neoplasms - mortality</subject><subject>Rectal Neoplasms - pathology</subject><subject>Rectal Neoplasms - surgery</subject><subject>Rectum</subject><subject>Review boards</subject><subject>Sphincter</subject><subject>Statistical analysis</subject><subject>Surgeons</subject><subject>Surgery</subject><subject>Survival</subject><subject>Treatments in Oncology</subject><subject>Tumors</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp10NtLwzAUBvAgipvTR1-lIIIv1dyay-MY88a8IPM5pOkpbLTNTNrB_ns7NgUF83II_Pg450PonOAbgjNx-zJ9evaWMsyo0AdoSDLGUs6xOERDjKlKudRsgE5iXOL-Ea6P0YBJKmnG-BCptwB-BcG2izUk8wC2raFpE18mM-9sVW2ScbG2jYMieQfX2iqZbH_hFB2Vtopwtp8j9HE3nU8e0tnr_eNkPEsd07hNcy1dITRIWcrc5lpL5bCSAjCljOdKsExYBQw0zYmgBIiizhGeC5ExyxUboetd7ir4zw5ia-pFdFBVtgHfRUMVpRIr0p8zQpd_6NJ3oem36xWnmeAab1W6Uy74GAOUZhUWtQ0bQ7DZVmp-Vdr7i31ql9dQ_OjvDntwtQN1HU0Dy_qfoC_Wr3nr</recordid><startdate>20230727</startdate><enddate>20230727</enddate><creator>Schrag, Deborah</creator><creator>Shi, Qian</creator><creator>Weiser, Martin R.</creator><creator>Gollub, Marc J.</creator><creator>Saltz, Leonard B.</creator><creator>Musher, Benjamin L.</creator><creator>Goldberg, Joel</creator><creator>Al Baghdadi, Tareq</creator><creator>Goodman, Karyn A.</creator><creator>McWilliams, Robert R.</creator><creator>Farma, Jeffrey M.</creator><creator>George, Thomas J.</creator><creator>Kennecke, Hagen F.</creator><creator>Shergill, Ardaman</creator><creator>Montemurro, Michael</creator><creator>Nelson, Garth D.</creator><creator>Colgrove, Brian</creator><creator>Gordon, Vallerie</creator><creator>Venook, Alan P.</creator><creator>O’Reilly, Eileen M.</creator><creator>Meyerhardt, Jeffrey A.</creator><creator>Dueck, Amylou C.</creator><creator>Basch, Ethan</creator><creator>Chang, George J.</creator><creator>Mamon, Harvey J.</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4334-5717</orcidid><orcidid>https://orcid.org/0000-0003-3813-9318</orcidid><orcidid>https://orcid.org/0000-0002-6249-9180</orcidid><orcidid>https://orcid.org/0000-0002-8076-9199</orcidid><orcidid>https://orcid.org/0000-0002-9912-1085</orcidid></search><sort><creationdate>20230727</creationdate><title>Preoperative Treatment of Locally Advanced Rectal Cancer</title><author>Schrag, Deborah ; Shi, Qian ; Weiser, Martin R. ; Gollub, Marc J. ; Saltz, Leonard B. ; Musher, Benjamin L. ; Goldberg, Joel ; Al Baghdadi, Tareq ; Goodman, Karyn A. ; McWilliams, Robert R. ; Farma, Jeffrey M. ; George, Thomas J. ; Kennecke, Hagen F. ; Shergill, Ardaman ; Montemurro, Michael ; Nelson, Garth D. ; Colgrove, Brian ; Gordon, Vallerie ; Venook, Alan P. ; O’Reilly, Eileen M. ; Meyerhardt, Jeffrey A. ; Dueck, Amylou C. ; Basch, Ethan ; Chang, George J. ; Mamon, Harvey J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-b97cd69e77f7bab9978c0876e02234b86356a8e3e92b1621e182cc14b6653a483</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>5-Fluorouracil</topic><topic>Adult</topic><topic>Anal Canal - surgery</topic><topic>Antineoplastic Combined Chemotherapy Protocols - adverse effects</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Cancer</topic><topic>Cancer therapies</topic><topic>Chemoradiotherapy</topic><topic>Chemoradiotherapy - adverse effects</topic><topic>Chemoradiotherapy - methods</topic><topic>Chemotherapy</topic><topic>Chemotherapy, Adjuvant</topic><topic>Colorectal cancer</topic><topic>Death</topic><topic>Disease-Free Survival</topic><topic>Fluorouracil - administration & dosage</topic><topic>Fluorouracil - adverse effects</topic><topic>Gastroenterology</topic><topic>Gastrointestinal Tract Cancer</topic><topic>Hematology</topic><topic>Humans</topic><topic>Leucovorin - administration & dosage</topic><topic>Leucovorin - adverse effects</topic><topic>Neoadjuvant Therapy</topic><topic>Neoplasm Recurrence, Local - drug therapy</topic><topic>Neoplasm Staging</topic><topic>Oncology</topic><topic>Organ Sparing Treatments</topic><topic>Oxaliplatin</topic><topic>Oxaliplatin - administration & dosage</topic><topic>Oxaliplatin - adverse effects</topic><topic>Pathology</topic><topic>Patients</topic><topic>Pelvis</topic><topic>Preoperative Care</topic><topic>Preoperative Period</topic><topic>Radiation therapy</topic><topic>Rectal Neoplasms - mortality</topic><topic>Rectal Neoplasms - pathology</topic><topic>Rectal Neoplasms - surgery</topic><topic>Rectum</topic><topic>Review boards</topic><topic>Sphincter</topic><topic>Statistical analysis</topic><topic>Surgeons</topic><topic>Surgery</topic><topic>Survival</topic><topic>Treatments in Oncology</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schrag, Deborah</creatorcontrib><creatorcontrib>Shi, Qian</creatorcontrib><creatorcontrib>Weiser, Martin R.</creatorcontrib><creatorcontrib>Gollub, Marc J.</creatorcontrib><creatorcontrib>Saltz, Leonard B.</creatorcontrib><creatorcontrib>Musher, Benjamin L.</creatorcontrib><creatorcontrib>Goldberg, Joel</creatorcontrib><creatorcontrib>Al Baghdadi, Tareq</creatorcontrib><creatorcontrib>Goodman, Karyn A.</creatorcontrib><creatorcontrib>McWilliams, Robert R.</creatorcontrib><creatorcontrib>Farma, Jeffrey M.</creatorcontrib><creatorcontrib>George, Thomas J.</creatorcontrib><creatorcontrib>Kennecke, Hagen F.</creatorcontrib><creatorcontrib>Shergill, Ardaman</creatorcontrib><creatorcontrib>Montemurro, Michael</creatorcontrib><creatorcontrib>Nelson, Garth D.</creatorcontrib><creatorcontrib>Colgrove, Brian</creatorcontrib><creatorcontrib>Gordon, Vallerie</creatorcontrib><creatorcontrib>Venook, Alan P.</creatorcontrib><creatorcontrib>O’Reilly, Eileen M.</creatorcontrib><creatorcontrib>Meyerhardt, Jeffrey A.</creatorcontrib><creatorcontrib>Dueck, Amylou C.</creatorcontrib><creatorcontrib>Basch, Ethan</creatorcontrib><creatorcontrib>Chang, George J.</creatorcontrib><creatorcontrib>Mamon, Harvey J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schrag, Deborah</au><au>Shi, Qian</au><au>Weiser, Martin R.</au><au>Gollub, Marc J.</au><au>Saltz, Leonard B.</au><au>Musher, Benjamin L.</au><au>Goldberg, Joel</au><au>Al Baghdadi, Tareq</au><au>Goodman, Karyn A.</au><au>McWilliams, Robert R.</au><au>Farma, Jeffrey M.</au><au>George, Thomas J.</au><au>Kennecke, Hagen F.</au><au>Shergill, Ardaman</au><au>Montemurro, Michael</au><au>Nelson, Garth D.</au><au>Colgrove, Brian</au><au>Gordon, Vallerie</au><au>Venook, Alan P.</au><au>O’Reilly, Eileen M.</au><au>Meyerhardt, Jeffrey A.</au><au>Dueck, Amylou C.</au><au>Basch, Ethan</au><au>Chang, George J.</au><au>Mamon, Harvey J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preoperative Treatment of Locally Advanced Rectal Cancer</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2023-07-27</date><risdate>2023</risdate><volume>389</volume><issue>4</issue><spage>322</spage><epage>334</epage><pages>322-334</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>In a trial comparing preoperative chemoradiotherapy and FOLFOX in patients with rectal cancer undergoing sphincter-sparing surgery, 5-year disease-free survival was 80.8% with FOLFOX and 78.6% with chemoradiotherapy.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>37272534</pmid><doi>10.1056/NEJMoa2303269</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-4334-5717</orcidid><orcidid>https://orcid.org/0000-0003-3813-9318</orcidid><orcidid>https://orcid.org/0000-0002-6249-9180</orcidid><orcidid>https://orcid.org/0000-0002-8076-9199</orcidid><orcidid>https://orcid.org/0000-0002-9912-1085</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0028-4793 |
ispartof | The New England journal of medicine, 2023-07, Vol.389 (4), p.322-334 |
issn | 0028-4793 1533-4406 |
language | eng |
recordid | cdi_proquest_miscellaneous_2822708125 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; New England Journal of Medicine |
subjects | 5-Fluorouracil Adult Anal Canal - surgery Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Cancer Cancer therapies Chemoradiotherapy Chemoradiotherapy - adverse effects Chemoradiotherapy - methods Chemotherapy Chemotherapy, Adjuvant Colorectal cancer Death Disease-Free Survival Fluorouracil - administration & dosage Fluorouracil - adverse effects Gastroenterology Gastrointestinal Tract Cancer Hematology Humans Leucovorin - administration & dosage Leucovorin - adverse effects Neoadjuvant Therapy Neoplasm Recurrence, Local - drug therapy Neoplasm Staging Oncology Organ Sparing Treatments Oxaliplatin Oxaliplatin - administration & dosage Oxaliplatin - adverse effects Pathology Patients Pelvis Preoperative Care Preoperative Period Radiation therapy Rectal Neoplasms - mortality Rectal Neoplasms - pathology Rectal Neoplasms - surgery Rectum Review boards Sphincter Statistical analysis Surgeons Surgery Survival Treatments in Oncology Tumors |
title | Preoperative Treatment of Locally Advanced Rectal Cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T19%3A19%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preoperative%20Treatment%20of%20Locally%20Advanced%20Rectal%20Cancer&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Schrag,%20Deborah&rft.date=2023-07-27&rft.volume=389&rft.issue=4&rft.spage=322&rft.epage=334&rft.pages=322-334&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMoa2303269&rft_dat=%3Cproquest_cross%3E2822708125%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2842564905&rft_id=info:pmid/37272534&rfr_iscdi=true |